{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:07:52Z","timestamp":1770919672719,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Health Labour Sciences Research Grant","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12890-017-0480-9","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T06:26:35Z","timestamp":1508999195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension"],"prefix":"10.1186","volume":"17","author":[{"given":"Asuka","family":"Furukawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Iwahori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narutaka","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,26]]},"reference":[{"issue":"6","key":"480_CR1","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1183\/09031936.00116313","volume":"43","author":"O Sitbon","year":"2014","unstructured":"Sitbon O, Ja\u00efs X, Savale L, Cottin V, Bergot E, Macari EA, Bouvaist H, Dauphin C, Picard F, Bulifon S, Montani D, Humbert M, Simonneau G. Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study. Eur Respir J. 2014;43(6):1691\u20137.","journal-title":"Eur Respir J"},{"issue":"26","key":"480_CR2","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","volume":"373","author":"O Sitbon","year":"2015","unstructured":"Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Gali\u00e8 N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV, Investigators GRIPHON. Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med. 2015;373(26):2522\u201333.","journal-title":"N Engl J Med"},{"key":"480_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2016.11.057","volume":"795","author":"C Fuchikami","year":"2017","unstructured":"Fuchikami C, Murakami K, Tajima K, Homan J, Kosugi K, Kuramoto K, Oka M, Kuwano KA. Comparison of vasodilation mode among selexipag (NS-304; [2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide]), its active metabolite MRE-269 and various prostacyclin receptor agonists in rat, porcine and human pulmonary arteries. Eur J Pharmacol. 2017;795:75\u201383.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"480_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00005344-200408000-00010","volume":"44","author":"K Laliberte","year":"2004","unstructured":"Laliberte K, Arneson C, Jeffs R, Hunt T, Wade M. Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers. J Cardiovasc Pharmacol. 2004;44(2):209\u201314.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3\u20134","key":"480_CR5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000367630","volume":"94","author":"S Bruderer","year":"2014","unstructured":"Bruderer S, Hurst N, Kaufmann P, Dingemanse J. Multiple-dose up-titration study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of selexipag, an orally available selective prostacyclin receptor agonist, in healthy subjects. Pharmacology. 2014;94(3\u20134):148\u201356.","journal-title":"Pharmacology"},{"key":"480_CR6","unstructured":"Study to Assess the Tolerability and the Safety of the Transition from Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension (TRANSIT-1). NCT02471183 \nhttps:\/\/clinicaltrials.gov\n\n."},{"key":"480_CR7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12890-015-0037-8","volume":"15","author":"M Kimura","year":"2015","unstructured":"Kimura M, Tamura Y, Takei M, Yamamoto T, Ono T, Fujita J, Kataoka M, Kuwana M, Satoh T, Fukuda K. Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study. BMC Pulm Med. 2015;15:62.","journal-title":"BMC Pulm Med"},{"key":"480_CR8","doi-asserted-by":"crossref","unstructured":"Sitbon O, Sattler C, Bertoletti L, Savale L, Cottin V, Ja\u00efs X, De Groote P, Chaouat A, Chabannes C, Bergot E, Bouvaist H, Dauphin C, Bourdin A, Bauer F, Montani D, Humbert M, Simonneau G. Initial dual oral combination therapy in pulmonary arterial hypertension. Eur Respir J 2016;47(6):1727-1736.","DOI":"10.1183\/13993003.02043-2015"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-017-0480-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T06:26:48Z","timestamp":1508999208000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-017-0480-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["480"],"URL":"https:\/\/doi.org\/10.1186\/s12890-017-0480-9","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,26]]},"article-number":"135"}}